Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,051 - 1,100 out of 13,556

Document Document Title
WO/2010/027108A1
Disclosed are a method for sensing saccharide-binding protein easily, quickly, and with high sensitivity, and a fluorescent compound necessary for this sensing. Specifically, disclosed is a method for sensing saccharide-binding protein t...  
WO/2010/023162A1
A new process for extracting and purifying glucosinolates from plant material, preferably broccoli sprouts or seeds is described. An alcoholic extract is adsorbed onto a basic resin and eluted with ammonia. Optionally, the alcoholic extr...  
WO/2010/023594A1
Compounds of Formula (I) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).The compounds disclosed her...  
WO/2009/112951A3
Method for preparing the disaccharide [α-D-Gldp(1→3)]-α-L-Rhap-YR wherein Y is selected from -O- and -S- and R is selected from the group consisting of: C1-C6 alkyl, C1-C6 alkenyl, aryl, allyl, -CO-alkyl (C1-C6), -CO-alkenyl (C1-C6),...  
WO/2008/134828A8
The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutica...  
WO/2010/018435A1
The invention relates to the O-glucosylated amide derivatives, which are inhibitors of Sodium dependent glucose co transporter (SGLT), particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 wit...  
WO/2010/018474A2
The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the co...  
WO/2009/135673A8
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2008/047249A3
The invention relates to α -galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods. It also relates to pharmaceutical compositions containing the α-galactoceramide analogs. The methods of ...  
WO/2010/014814A2
The present invention discloses a set of glycosylated warfarin analogs which are useful as anti-tumor or anti-metastatic agents and as reagents for studying sugar uptake in cells.  
WO/2009/126737A3
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/112950A3
Method for preparing the disaccharide α-D-glucopyranosyl-(1→4)- 2-N-acetyl-2-deoxy-α-D-glucopyranoside, comprising the step of using a mutant of a wild type glycoside hydrolase.  
WO/2009/156324A2
Described is the use of benzotropolone and their derivatives, especially the compounds of formula (1); wherein R2, R3, R4, R5 and R6 independently of one another are hydrogen; OH; C1-C30alkyl, C2-C30al- kenyl, C1-C30alkoxy, C3-C12cycloal...  
WO/2009/135673A3
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/153434A2
The present invention relates to novel synthetic analogues of phosphatidyl-myo-inositol mannosides (hereinafter referred to as PIMs) of general formula (I): or a pharmaceutically acceptable salt thereof, to the method for preparing same ...  
WO/2009/153509A2
Composition (C) comprising, per 100% of its weight: - from 10 wt% to 95 wt%, more particularly from 70 wt% to 95 wt% of one or more alcohol ethers of glycerol of formula (II): in which R1 represents a linear or branched, saturated or uns...  
WO/2009/150022A2
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/150023A2
The invention relates to the enzymatic synthesis of sphingolipids and compositions that contain sphingolipids from lysosphingolipids and carbonic esters, and to cosmetic, dermatological or pharmaceutical formulations containing said sphi...  
WO/2009/060086A3
The present invention relates to compounds consisting of glycolipids covalently bound to an antigen or a drug via a linker. The said compounds are able to induce a stronger immune response than a composition comprising separated glycolip...  
WO/2009/143630A1
Compounds produced by combining imino sugars and creatine and salts thereof are herein disclosed. The compounds being in the form of creatine imino sugar amides and the salts being combinations of various creatine imino sugar amides with...  
WO/2009/108680A3
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/143930A1
A process for the preparation of compounds having formula (I) is disclosed, wherein: - R1 is a methoxy or methylthio group; - R2 is a O-glycosyloxy residue. Compounds having formula (I) are prepared by reacting the corresponding precurso...  
WO/2009/117196A8
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2009/107853A3
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  
WO/2009/139719A1
The present invention relates to novel synthesis routes for preparation of thiodigalactosides of the general formula (12). The method comprises the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corres...  
WO/2009/135673A2
Compounds of the general formula (I) and (II) (including formulae (III) to (V)), wherein X - -CH2-, -O-, -S- n = 0-10 Y = -NH-, -NHSO2-, -NHSO-, -NHCO-, -S-, -O-, -CH=CH- R1-R7, equal or different can be hydrogen, alkyl C1-C4, alkenyl C2...  
WO/2009/133269A1
The invention relates to compounds of the formula (I) in which R1, R2 and R3 are identical or different and each represent a hydrogen atom or a group of the formula (A). The invention can be used for drugs.  
WO/2009/134570A2
Disclosed are tri-nuclear metal complexes and salts thereof, such as tri-nuclear osmium or ruthenium complexes or salts thereof, suitable for use as electrochemical labels. Also disclosed are oligonucleotide probes with an attached elect...  
WO/2009/081211A3
A process of obtaining a saponin-rich component from a plant of the Araliaceae family, the process comprising the steps of: (a) treating a portion of the plant with an extraction solvent in which saponin-containing compounds are soluble;...  
WO/2009/127339A1
The present invention relates to nanoemulsions comprising alkyl and/or alkenyl ethers of alkyl and/or alkenyl(poly)glycosides, a method for the production thereof and use thereof. The present invention further relates to alkyl and/or alk...  
WO/2009/126556A1
Compounds, compositions and methods are provided for treatment of diseases or complications associated therewith, in which a selectin plays a role. More specifically, particular glycomimetics and uses thereof are described. For example, ...  
WO/2009/125819A1
Disclosed is a compound useful as an active ingredient for a pharmaceutical composition having an α-amylase-inhibiting activity, particularly a pharmaceutical composition for the treatment of diabetes. Studies have been made for discove...  
WO/2009/126737A2
The present invention relates to triterpene glycoside saponin-derived adjuvants, syntheses thereof, intermediates thereto, and uses thereof. QS-7 is a potent immuno-adjuvant that is significantly less toxic than QS-21, a related saponin ...  
WO/2009/124468A1
Anthracycline antibiotic derivatives with anticancer activity, i.e. the compounds of formula (I). The present anthracycline antibiotic derivatives has the same activity as or higher activity than that of the known medicaments such as dox...  
WO/2009/121939A2
This invention relates to a compound of generic formula (I): (I) as well as a pharmaceutically acceptable salt thereof, a tautomer, optical isomer or a mixture of optical isomers in any proportion, in particular a mixture of enantiomers,...  
WO/2009/119692A1
Disclosed are: a novel glycolipid effective for the treatment of caner or the like; a novel intermediate for the synthesis of the novel glycolipid; a pharmaceutical agent comprising the novel glycolipid; and others. Specifically disclose...  
WO/2009/117196A1
Methods for utilizing the anticancer properties of terpenoid saponin compounds so as to modulate adhesion proteins, inhibit angiogenesis in tumors, modulate gene expression, modulate angiopoietin, enhance an immune response, provide adju...  
WO/2008/059035A3
The present invention relates to a novel process for the chemical synthesis of β-(1->6)-linked glucosamine disaccharides of the fomula (1) and (intermediate) compounds relating to the process. According to further aspects the invention ...  
WO/2008/134828A3
The present invention provides isolated or essentially pure diterpenoic tetrahydropyran, such as steviol-19-glucuronide, steviol, stevioside and rebaudioside processes for obtaining the same and methods for obtaining stable pharmaceutica...  
WO/2008/151615A3
The invention relates to a method for producing biosurfactants, according to which micro-organisms producing biosurfactants are moved in a nutrient substrate. According to the invention, the nutrient substrate is used in excess and a mec...  
WO/2009/107853A2
An agent for preventing or ameliorating skin aging, which exhibits a more excellent effect on the suppression of formation, or the amelioration, of wrinkles on the skin or sagging skin. An agent for preventing or ameliorating skin aging,...  
WO/2009/108680A2
Exemplary embodiments of this invention encompass a method for degrading rebaudioside A and the rebaudioside A derivative products derived therefrom. In particular, this invention relates to a method for degrading rebaudioside A composit...  
WO/2009/102736A1
The invention disclosed in this document is related to the field of pesticides and their use in controlling pests. A compound having the following structure is disclosed.  
WO/2008/092690A8
The present invention relates to paromamine-based compounds according to formula (I) having selective antimicrobial activity directed at ribosomal 16S RNA. Furthermore, the invention is directed to the use of said compounds for preparing...  
WO/2009/101213A1
The present invention relates to an enzyme called chitinosanase which is obtained from the fungus Alternaria alternate, said enzyme breaking down chitosane and specifically cleaving the glycosidic GIcNAc-GIcN bond in chitosane, DNA seque...  
WO/2009/098400A1
The invention relates to a chemical compound of the disaccharide type of the following general formula (A): where, Z = O or S; X1 = azido or NHCOR3 where R3 = 1 -5 c alkyl or aryl, X2 = benzyl, H or sulfonate, X3 = -CH2φ, -CHφ forming ...  
WO/2009/096503A1
Disclosed is a compound having a novel structure, few adverse side effects and an excellent inhibitory activity on human SGLT1 and/or SGLT2, or a hydrate of the compound. Also disclosed is a pharmaceutical composition for treating and/or...  
WO/2009/095588A2
The invention relates to compounds of the formula (I) in which: R1 = OH or NH2; OR2, OR3, OR4 and OR5 form alcohol, ether, ester, carbonate, carbamate, sulphonate or sulphamate functions; and if R5 = H, if R2 =R3=R4, then R2, R3 and R4 ...  
WO/2009/097596A1
The present disclosure provides compositions and methods for the treatment and elimination of chronic intracellular infections in cells or organisms. The compositions may include one or more acidic substances and one or more antimicrobia...  
WO/2009/093604A1
This object aims to provide an organic nanotube manufacturing method and an organic nanotube manufacturing device that pressurize an organic nanotube material dispersion solution comprised of an organic nanotube material and an organic s...  

Matches 1,051 - 1,100 out of 13,556